Vitura HealthASX:VIT PS Ratio is 0.13 as of Jul. 06, 2026, which is 94% below its 10-year median of 2.19. The stock has 8 warning signs investors should review. Among 952 Drug Manufacturers companies, Vitura Health ranks better than 98.63% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Vitura Health's share price is A$0.027.
Vitura Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.20. Hence, Vitura Health's PS Ratio for today is 0.13.
The historical rank and industry rank for Vitura Health's PS Ratio or its related term are showing as below:
ASX:VIT'
s PS Ratio Range Over the Past 10 Years
Min: 0.11 Med: 2.19 Max: 155
Current: 0.13
During the past 7 years, Vitura Health's highest PS Ratio was 155.00. The lowest was 0.11. And the median was 2.19.
ASX:VIT's PS Ratio is ranked better than 98.63% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs ASX:VIT: 0.13
Vitura Health Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Vitura Health was -7.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 175.10% per year.
During the past 7 years, Vitura Health's highest 3-Year average Revenue per Share Growth Rate was 490.60% per year. The lowest was 14.00% per year. And the median was 155.60% per year.
Back to Basics: PS Ratio
Vitura Health (ASX:VIT) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Vitura Health PS Ratio Related Terms
Vitura Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Vitura Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitura Health PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vitura Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Vitura Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Vitura Health's Share Price of today is A$0.027.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vitura Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Vitura Health (ASX:VIT) has a PS Ratio of 0.13 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Vitura Health and its competitors. This is 94% below median its historical median of 2.19. Over the past decade, Vitura Health's PS Ratio has ranged from 0.11 to 155.00. According to the industry distribution chart, Vitura Health ranks #13 out of 952 companies in the Drug Manufacturers industry, placing it in the top 1.4%.
Is Vitura Health's PS Ratio too high?
Vitura Health's current PS Ratio of 0.13 is 94% below median its 10-year median of 2.19. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 155.00. The Drug Manufacturers industry median PS Ratio is 2.32. Vitura Health's value of 0.13 is 94.4% below this industry median. Based on the distribution chart, Vitura Health ranks #13 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Vitura Health's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vitura Health ranks #13 out of 952 companies for PS Ratio. This places Vitura Health in the top 1% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.32. Vitura Health's value of 0.13 is 94.4% below this benchmark. Historically, Vitura Health's own PS Ratio has ranged from 0.11 to 155.00 over the past decade. While the company's 10-year median is 2.19 vs. the industry median of 2.32, Vitura Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitura Health's current PS Ratio of 0.13 is 94.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Vitura Health and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitura Health's current PS Ratio is 0.13, which is 94% below median its own 10-year median of 2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitura Health stock overvalued right now?
Based on GuruFocus' analysis, Vitura Health (ASX:VIT) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.03 — trading 73% below its estimated fair value. The current PS Ratio is 0.13, which is 94% below median its 10-year median of 2.19 and 94.4% below the Drug Manufacturers industry median of 2.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Vitura Health (ASX:VIT), the current PS Ratio is 0.13 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VIT has been successfully added to your 